Skip to main content
IDDO Logo
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
    • Jobs
  • Data
    • Explore data
    • Accessing data
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
    • Data Access Guidelines
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
    • Jobs
  • Data
    • Explore data
    • Accessing data
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
    • Data Access Guidelines
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
LOGIN
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

WWARN News

Please visit WWARN's website for regular updates on malaria and sign up for the WWARN newsletter here. 

Credit: Pearl Gan
Thursday, 29 January 2015

WWARN at ASTMH Annual Meeting 2013

Thursday, 29 January 2015

A quick overview of Malaria funding in the US

Thursday, 29 January 2015

WHO appoints new Director of the Global Malaria Programme

Thursday, 29 January 2015

Join the MSF Online Journal Club this week on malaria

Thursday, 29 January 2015

Two new tests distinguish drug-resistant from drug-susceptible parasites

Thursday, 29 January 2015

Event announcement: Artemesinin Resistance - threats and responses

Thursday, 29 January 2015

WHO put the spotlight on artemisinin resistance

Thursday, 29 January 2015

Challenges in antimalarial drug resistance

Thursday, 29 January 2015

Prof. Nick White prepares seminar on antimalarial resistance

Thursday, 29 January 2015

Mass primaquine treatment to eliminate vivax malaria: lessons from the past

Thursday, 29 January 2015

WHO call for urgent action to reduce monotherapies

Thursday, 29 January 2015

MIM release final symposium programme

Thursday, 29 January 2015

Revealing molecular strategies to preserve drug efficacy

Thursday, 29 January 2015

New African Network exploring diversity of malaria

Thursday, 29 January 2015

Join us at 6th MIM Pan-African Malaria Conference in Durban, South Africa

Thursday, 29 January 2015

The Millennium Development Goals (MDG) agenda post 2015: drugs, cure or curse?

Thursday, 29 January 2015

Latest study confirms further spread and emergence of antimalarial resistance in Southeast Asia

The latest study published in the New England Journal of Medicine, confirms that resistance to the current frontline antimalarial, artemisinin, is now present in Eastern Myanmar, Thailand and Southern Vietnam, as well as Western Cambodia.
Thursday, 29 January 2015

Windows Phone 7 App Fights Malaria

Thursday, 29 January 2015

New study suggests malaria deaths may be underestimated

Thursday, 29 January 2015

Artemisinin resistance on the Thai-Myanmar border

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Current page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • …
  • Next page ››
  • Last page Last »

  • Navigation
    • About
  • Contact
    • info@iddo.org
  • Socials
    • LinkedIn
  • Newsletters
    • IDDO Newsletter
IDDO Footer logo
© 2026 Infectious Diseases Data Observatory
  • Cookies |
  • Privacy Notice |
  • Accessibility |
  • Sitemap |
  • Terms of use